• OPEN AN ACCOUNT
Indian Indices
Sensex
81,106.65 107.25
( 0.13%)
Global Indices
Nasdaq
52,540.96 1,234.23
(2.41%)
Dow Jones
7,582.98 185.12
(2.50%)
Hang Seng
58,738.13 1,303.36
(2.27%)
Nikkei 225
10,779.79 105.85
(0.99%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
130.93
457073.31
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.84
 

Newtime Infrastructure reports consolidated net loss of Rs 3.62 crore in the March 2026 quarter
Jun 01,2026
Net loss of Newtime Infrastructure reported to Rs 3.62 crore in the quarter ended March 2026 as against net profit of Rs 0.31 crore during the previous quarter ended March 2025. Sales remain constant at Rs 0.95 crore in the quarter ended March 2026 and also during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 5.42 crore in the year ended March 2026 as against net loss of Rs 3.08 crore during the previous year ended March 2025. Sales declined 27.71% to Rs 3.73 crore in the year ended March 2026 as against Rs 5.16 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.950.95 0 3.735.16 -28
OPM %-248.42-3.16 --71.58-0.19 -
PBDT-4.11-0.35 -1074 -6.23-2.89 -116
PBT-4.12-0.37 -1014 -6.28-2.94 -114
NP-3.620.31 PL -5.42-3.08 -76